Search - tctmd.com

Displaying 261 - 280 of 287

Sort: Relevancy | Date

News Daily News

La Denervación Pulmonar es Prometedora contra la Hipertensión Pulmonar Resistente

Yael L. Maxwell

July 19, 2013

News Industry News

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

June 04, 2013

News Industry News

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

May 23, 2013

News Conference News SCAI 2013

POSEIDON: Sliding-Scale Hydration Prevents CIN, Adverse Events at 6 Months

Yael L. Maxwell

May 09, 2013

News Daily News

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

April 26, 2013

News Daily News

Directrices de la ESC sobre el Uso Apropiado de la Denervación Renal basada en Catéter

April 26, 2013

News Daily News

Women vs. Men in BARI 2D: Equal Survival but Worse Quality of Life

March 09, 2013

News Daily News

Mujeres frente a Hombres en el BARI 2D: Misma Supervivencia pero Peor Calidad de Vida

March 09, 2013

News Daily News

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Yael L. Maxwell

December 13, 2012

News Daily News

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Yael L. Maxwell

December 13, 2012

News Daily News

Test May Detect STEMI Patients at Risk for Contrast Nephropathy After PCI

Jason Kahn

December 03, 2012

News Daily News

Un Test Podría Detectar qué Pacientes STEMI corren Riesgo de sufrir Nefropatía por Contraste tras someterse a una PCI

Jason Kahn

December 03, 2012

News Industry News

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

November 04, 2012

News Conference News AHA 2012

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

Jason Kahn

November 04, 2012

News Conference News TCT 2012

POSEIDON: Sliding-Scale Hydration Successfully Prevents Contrast-Induced Nephropathy

October 25, 2012

News Industry News

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

October 01, 2012

News Daily News

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

June 05, 2012

News Industry News

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

May 16, 2012

News Conference News ACC 2012

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Yael L. Maxwell

March 27, 2012

News Daily News

Acute Kidney Injury Incidence Down in AMI Patients Despite High Risk Factors

March 23, 2012

Advertisement

La Denervación Pulmonar es Prometedora contra la Hipertensión Pulmonar Resistente

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

POSEIDON: Sliding-Scale Hydration Prevents CIN, Adverse Events at 6 Months

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

Directrices de la ESC sobre el Uso Apropiado de la Denervación Renal basada en Catéter

Women vs. Men in BARI 2D: Equal Survival but Worse Quality of Life

Mujeres frente a Hombres en el BARI 2D: Misma Supervivencia pero Peor Calidad de Vida

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Test May Detect STEMI Patients at Risk for Contrast Nephropathy After PCI

Un Test Podría Detectar qué Pacientes STEMI corren Riesgo de sufrir Nefropatía por Contraste tras someterse a una PCI

Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months

Early Study Shows Positive Clinical Results with Novel Renal Denervation Device

POSEIDON: Sliding-Scale Hydration Successfully Prevents Contrast-Induced Nephropathy

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

Renal Denervation: Treatment for Hypertension Captures Interventional Spotlight

Renal Denervation Technology from St. Jude Medical Demonstrates Significant Reduction in Blood Pressure

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Acute Kidney Injury Incidence Down in AMI Patients Despite High Risk Factors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content